COMMUNIQUÉS West-GlobeNewswire

BioAegis Therapeutics Unveils Upcoming Clinical Study of Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)
27/02/2024
Large phase 2 global study will evaluate efficacy and safety of recombinant human plasma gelsolin (rhu-pGSN) for moderate-to-severe ARDS. NORTH BRUNSWICK, N.J., Feb. 27, 2024 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, a [...]
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
27/02/2024
Company Announcement COPENHAGEN, Denmark; February 27, 2024 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
27/02/2024
Company Announcement COPENHAGEN, Denmark; February 27, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 48,429 shares as a consequence of the exercise of employee warrants. The increase is effected [...]
Aclarion Announces Closing of $3.0 Million Public Offering
27/02/2024
BROOMFIELD, CO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW) , a healthcare technology company that is leveraging biomarkers and proprietary [...]
Gain Therapeutics Announces the Initiation of the Multiple Ascending Dose (MAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-targeting Small Molecule Therapy for GBA1 Parkinson’s Disease
27/02/2024
BETHESDA, Md., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of [...]
Atrion Corporation Declares Quarterly Cash Dividend
27/02/2024
ALLEN, Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock. [...]
Renowned scientist Gavriel Dardashti has embarked on a groundbreaking research project that could potentially lead to a major scientific breakthrough
27/02/2024
MIAMI, Feb. 27, 2024 (GLOBE NEWSWIRE) -- New research in electrodynamics unveils enhanced treatment at Ibogaine by David Dardashti. Quantum electrodynamics is a branch of physics that studies the interactions between [...]
Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada
27/02/2024
Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Maxigesic® IV, a Potent Non-opioid Painkiller, Marketed in the U.S. under the Tradename Combogesic® IV Maxigesic® IV approved in Canada Liège [...]
Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada
27/02/2024
Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada Maxigesic® IV, puissant analgésique non opioïde, commercialisé aux États-Unis sous le nom de Combogesic® IV Maxigesic® IV [...]
NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
27/02/2024
CARMEL, Ind., Feb. 27, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS), (“NeurAxis,” or the “Company”), a medical technology company commercializing neuromodulation therapies that address chronic and [...]
MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor
27/02/2024
New Scientific Advisory Board member played instrumental role in FDA approval and commercialization of multiple blockbuster products CHICAGO, IL, Feb. 27, 2024 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE [...]
FamilyWell’s Oversubscribed $4.3M Seed Round Led by .406 Ventures
27/02/2024
The startup is making it easier for new mothers to access mental health care by integrating support directly into Obstetric practices Boston, MA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- FamilyWell Health has secured $4.3 [...]
SURVEY: 31% of Hospital Nurse Leaders Plan to Change Jobs in the Next Year
27/02/2024
Burnout Common Among Hospital Chief Nursing Officers and Other Nurse Leaders DALLAS, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Close to one third of hospital nurse leaders (31%) plan to leave their jobs in the next year, [...]
Derm-Biome Pharmaceuticals prepares to begin IND-enabling studies for DB-007-4, a potential best-in-class treatment for inflammatory skin diseases
27/02/2024
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver-based biopharmaceutical company developing novel topical therapies for inflammatory skin diseases and skin [...]
Pulsed Field Ablation Innovator Argá Medtech Announces €54 Million Oversubscribed Series B Capital Raise
27/02/2024
- Funding will advance US and EU clinical studies of innovative pulsed field ablation system for treating atrial fibrillation - - Funding will advance US and EU clinical studies of innovative pulsed field ablation [...]
Empowering Women in Dentistry: Austin Oral Surgery’s 2024 Lucy Hobbs Project Seeks to Overcome Burnout, Cultivate Belonging and End Human Trafficking
27/02/2024
AUSTIN, Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) -- In honor of women’s history month, Austin Oral Surgery will host its fourth annual Lucy Hobbs Project , March 1 from 9 a.m. until 4 p.m. at The Norris Center in Austin. [...]
High school CPR trained students saving lives across Canada
27/02/2024
OTTAWA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- When 15-year-old Madeleine Caza’s father suffered a sudden cardiac arrest, her quick-thinking heroics and use of CPR helped save his life. Madeleine was trained through the ACT [...]
Des élèves du secondaire formés en RCR sauvent des vies partout au Canada
27/02/2024
OTTAWA, 27 févr. 2024 (GLOBE NEWSWIRE) -- Lorsque le père de Madeleine Caza, 15 ans, a subi un arrêt cardiaque soudain, sa rapidité d'esprit et son recours à la RCR ont contribué à lui sauver la vie. Madeleine a été [...]
Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3
27/02/2024
Myriad’s Precise MRD test will be used to evaluate the broad applicability of MRD testing across many cancer types SALT LAKE CITY, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in [...]

Pages